Progressive hearing loss in Fabry's disease: A case report

European Archives of Oto-Rhino-Laryngology

Volumn 263, Issue 7, 2006, Pages 688-691

  Barras, Florian M ^a   Maire, Raphaël ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Fabry's disease; Hearing loss; Inner ear; Sudden deafness

Indexed keywords

ALPHA GALACTOSIDASE; CORTICOSTEROID; CYCLOSPORIN; GLYCOSPHINGOLIPID; LYSOSOME ENZYME; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; AUDIOLOGY; CASE REPORT; DISEASE COURSE; DIZZINESS; ENZYME DEFICIENCY; FABRY DISEASE; HEARING AID; HEARING LOSS; HEARING TEST; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INNER EAR; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; MALE; PATIENT REFERRAL; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PURE TONE AUDIOMETRY; SPEECH DISCRIMINATION; X CHROMOSOME LINKED DISORDER;

AUDIOMETRY, PURE-TONE; AUDIOMETRY, SPEECH; AUDITORY THRESHOLD; DISEASE PROGRESSION; DIZZINESS; EAR, INNER; FABRY DISEASE; HEARING LOSS, SENSORINEURAL; HUMANS; MALE; MIDDLE AGED;

EID: 33745488601     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-006-0023-0     Document Type: Article

References (12)

1. Meikle PJ, Hopwood JJ, Clague AE, Carey MF (1999) Prevalence of lysosomal storage disorders. Jama 281:49-54
2. Germain DP, Avan P, Chassaing A, Bonfils P (2002) Patients affected with Fabry disease have an increased incidence of progressive hearing loss and sudden deafness: an investigation of twenty-two hemizygous male patients. BMC Med Genet 3:10
3. MacDermot KD, Holmes A, Miners AH (2001) Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet 38:750-760
4. Mitsias P, Levine SR (1996) Cerebrovascular complications of Fabry's disease. Ann Neurol 40:8-17
5. Morgan SH, Rudge P, Smith SJ, Bronstein AM, Kendall BE, Holly E, Young EP, Crawfurd MD, Bannister R (1990) The neurological complications of Anderson-Fabry disease (alpha-galactosidase A deficiency)-investigation of symptomatic and presymptomatic patients. Q J Med 75:491-507
6. Schachern PA, Shea DA, Paparella MM, Yoon TH (1989) Otologic histopathology of Fabry's disease. Ann Otol Rhinol Laryngol 98:359-363
7. Ozturan O, Lam S (1998) The effect of hemodialysis on hearing using pure-tone audiometry and distortion-product otoacoustic emissions. ORL J Otorhinolaryngol Relat Spec 60:306-313
8. Stavroulaki P, Nikolopoulos TP, Psarommatis I, Apostolopoulos N (2001) Hearing evaluation with distortion-product otoacoustic emissions in young patients undergoing haemodialysis. Clin Otolaryngol 26:235-242
9. Hilz MJ (2002) Evaluation of peripheral and autonomic nerve function in Fabry disease. Acta Paediatr Suppl 91:38-42
10. Breunig F, Wanner C (2003) Enzyme replacement therapy for Fabry disease: proving the clinical benefit. Nephrol Dial Transplant 18:7-9
11. Breunig F, Weidemann F, Beer M, Eggert A, Krane V, Spindler M, Sandstede J, Strotmann J, Wanner C (2003) Fabry disease: diagnosis and treatment. Kidney Int Suppl 84:181-185
12. Desnick RJ, Brady R, Barranger J, Collins AJ, Germain DP, Goldman M, Grabowski G, Packman S, Wilcox WR (2003) Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 138:338-346